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Abstract: Rutin is a well-known antioxidant from the group of flavonoids. Its use in cosmetic dermal
products is, however, limited due to its poor water solubility. In order to increase rutin saturation
solubility and improve the diffusion to the skin, rutin nanocrystals were produced by the smartCrystal
process, e.g., bead milling followed by high pressure homogenization. Rutin nanocrystals were
further incorporated into hydroxypropyl cellulose (HPC) gel and its long-term stability was assessed.
Determination of the antioxidant activity was made by the DPPH (2,2-diphenyl-1-picrylhydrazyl)
assay for these formulations: rutin nanocrystals (mean size 300 nm), rutin raw drug powder
(mean size 33 µm) and commercial product. Furthermore, the skin penetration profile of rutin
was investigated by the tape-stripping method on porcine skin. This study demonstrated that rutin
nanocrystal gel had the highest neutralizing activity (90%), followed by a commercial product and
rutin raw drug powder. According to the skin study, rutin nanocrystals penetrated to the deeper
layers of the stratum corneum, the horny layer of the skin.
Keywords: rutin; nanocrystals; smartCrystals; poor solubility; in vitro antioxidant activity; DPPH
assay; radical scavenging; ex vivo penetration study; tape stripping; bioactivity
1. Introduction
The human skin is constantly and directly exposed to stressful environmental factors such as
solar radiation or pollution, both of which induce the generation of aggressive free radicals as well
as reactive oxygen species (ROS). Free radicals are characterized by one or more unpaired electrons
and are able to enter into destructive chemical bonds with proteins of the skin, causing chemical and
functional changes of the skin matrix [1]. ROS also attack and react with the skin cell molecules in the
dermis, causing wrinkles due to the cross-linking of collagen and elastin [2]. In addition, it lessens the
self-repair ability of the skin [3]. To a certain degree, endogenous melanin and enzymatic antioxidants
are able to neutralize ROS. For prevention of oxidative stress, a term referring to the imbalance between
the generation of ROS and the antioxidant defense activity [4], and to enhance the reparation of the
DNA, exogenous antioxidants should be applied topically.
Flavonoids, in particular rutin, proved its pronounced antioxidant property on molecular level
in several studies [5]. The exceptional antioxidant activity of rutin can be ascribed to its phenolic
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compound characterized by an aromatic ring linked to a hydroxyl group, which has an ability to
donate electron and hydrogen [6]. Nevertheless, rutin cannot be used efficiently in dermal products
because of its insufficient penetration rate into the skin. However, a pronounced penetration of the
antioxidant is required, since the antioxidant has to neutralize the reaction of ROS within cell molecules
located in the dermis [2]. The poor penetration of rutin into the skin is a result of its low solubility in
both aqueous and organic solvents. Generally, skin penetration can by described by a passive diffusion
process, which is more pronounced, the higher is the concentration gradient to the skin. Since only
dissolved rutin is able to create such a concentration gradient, insufficient penetration occurs. Thus,
the solubility of rutin has to be increased significantly for its efficient use as dermal antioxidant.
Nanocrystals were originally developed for oral and intravenous administration of poorly soluble
drugs. Several years later, the dermal application of nanocrystals was described in a patent [7,8].
In comparison to other drug formulations (such as polymeric nanoparticles), nanocrystals are made
from pure cosmetic active and do not require the use of organic solvents. Nanocrystals dermal
penetration enhancement might be explained by three various effects:
1. The increased saturation solubility of nanosized rutin and subsequently increased concentration
gradient between dermal formulation and skin, leading to increased diffusion into the skin.
2. The increased dissolution velocity caused by the large surface area of the nanocrystals.
3. High adhesion to skin, as all nanosized materials are adhesive.
Due to their size in the nano-dimension, nanocrystals possess higher kinetic saturation solubility,
and, in combination with the large surface, it leads to fast dissolution. These effects have already been
described for rutin nanocrystals developed for oral administration [9,10]. Thus, rutin nanocrystals
were produced for dermal application in this study.
The production technology employed is the smartCrystal process, a combination technology. The
raw drug powder is dispersed in a surfactant solution (= macro-suspension), and then passed several
times through a bead mill containing milling beads. The obtained nano-suspension is subsequently
passed through a high pressure homogenizer at low pressure [9,11]. This yields a more uniform
product in size with increased physical stability compared to applying a mono process, e.g., bead
milling or high pressure homogenization only [7]. This is of special interest for dermal formulations,
because they often contain suspension-destabilizing agents such as electrolytes or preservatives.
An increased in vivo bioactivity in the skin for rutin nanocrystals has already been observed in
a human study. The subjects were irradiated after application of the two test formulations, and the
increase in the sun protection factor (SPF) was determined (= measure for antioxidant activity in
the skin). A formulation with water-soluble rutin derivative (glucoside) in a concentration of 5.0%
versus a formulation with only 0.01% dissolved rutin from rutin nanocrystals was applied. Despite the
500 times lower dissolved concentration, the rutin nanocrystal formulation had a two-fold increased
SPF [7], which in simpler terms means a 1000-fold higher bioactivity in skin.
2. Experimental Section
2.1. Materials
2,2-Diphenyl-1-picrylhydrazyl, polysorbate 80 and hydroxypropyl cellulose (HPC) were
purchased from Sigma-Aldrich (St. Louis, MO, USA), Glycerol 85% was purchased from LS
Labor-Service GmbH (Gründau, Germany) and euxyl® PE 9010 was purchased from Schülke &
Mayr GmbH (Norderstedt, Germany). Methanol, dimethyl sulfoxide and acetonitrile were obtained
from VWR International (Radnor, PA, USA) in High-Performance Liquid Chromatography (HPLC)
quality. Purified water was from a Milli-Q system of Merck KGaA (Darmstadt, Germany). Rutin raw
drug powder was kindly provided from PharmaSol GmbH (Berlin, Germany).
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2.2. Production of Rutin Nanocrystal (smartCrystal) Suspension
The rutin nano-suspension was produced by combining wet bead milling with high pressure
homogenization (HPH), the so-called smartCrystal process [7]. First, a rutin nano-suspension
concentrate consisting of 18.0% rutin, 2.0% polysorbate 80, 1.0% euxyl® PE 9010 and water for injection
up to 100% was prepared by wet bead milling using a PML-2 (Bühler AG, Uzwil, Switzerland)
at 2000 rpm and pump capacity of 10% with 0.4–0.6 mm yttria oxide stabilized zirconium oxide
beads (Hosokawa Alpine, Augsburg, Germany). This concentrate was further diluted to the final
concentration of 5.0% rutin, 2.0% polysorbate 80, 5.0% glycerol 85.0%, and 1.0% euxyl® PE 9010
and processed for two cycles of HPH at 300 bar using an EmulsiFlex-C50 (Avestin Europe GmbH,
Mannheim, Germany).
2.3. Production of Rutin Containing Gel Formulation
The hydrophilic gel base for rutin incorporation was prepared by dispersing 5.0% hydroxypropyl
cellulose (HPC) in 85 ˝C hot purified water at 87.5%. Mortar and pestle were used to stir the dispersion
until room temperature was reached and a homogenous gel was formed. A deficiency in weight
occurs due to evaporated water. Thus, it was complemented. For the improvement of spreading
properties, glycerol 85% at 2.5% was added dropwise as well as the preserving agent euxyl® PE 9010
at 1.0%. Finally, 4.0% rutin nanocrystal suspension was incorporated into the prepared gel base,
corresponding to 0.2% pure rutin nanocrystals in the whole formulation (= 100%). For the production
of a reference gel, identical gel base as that mentioned above was used. Instead of incorporating the
rutin nano-suspension (Section 2.2), 4.0% of a rutin bulk powder suspension with identical composition
as the nano-suspension (5.0% rutin, 2.0% polysorbate 80, 5.0% glycerol 85%, 1.0% euxyl® PE 9010,
up to 100.0% water) was incorporated.
2.4. Characterization of Nanocrystals
2.4.1. Photon Correlation Spectroscopy (PCS)
z-averages (intensity weighted mean diameter of the bulk population) and polydispersity indices
(representing the width of the size distribution) of produced nanocrystal suspensions were analyzed
by PCS using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK). The samples were
diluted (10 µL nanocrystal suspension in 5.0 mL purified water) and the mean values were calculated
from 10 single measurements. To analyze the particle size of rutin incorporated into gel, 50.0 mg of the
prepared rutin gel was suspended in 100 mL purified water and 1.0 mL of it was diluted with purified
water up to 100 mL.
2.4.2. Laser Diffractometry (LD)
For the detection of larger particles or agglomerations outside of the PCS measurement range, LD
measurements were performed using a Mastersizer 2000 (Malvern Instruments, Worcestershire, UK).
As dispersion medium purified water was used. The real refractive index of rutin particles was set
to 1.456 with an imaginary refractive index of 0.01. The obscuration range was set between 4% and
6% and the stirring speed to 750 rpm with no sonication. As characteristic parameters, LD volume
weighted diameters LD 50%, 90% and 99% were used.
2.4.3. Light Microscopy (LM)
For fast detection of large particles and aggregates within the formulation and for the confirmation
of LD data, LM was performed with an Orthoplan Leitz (Wetzlar, Germany) at magnifications of 100,
400 and 1000. For visual documentation, the microscope was connected to a digital camera CMEX 3200
(Arnhem, The Netherlands). Samples were analyzed undiluted to increase the probability of finding
even a few large particles or aggregates.
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2.4.4. Zeta Potential (ZP)
For the prediction of the suspension’s long-term stability, the electrophoretic mobilities of the
particles were determined using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK).
The measurement was performed in both conductivity-adjusted water (50 µS/cm with NaCl solution
and pH of 5.5) and original dispersion medium. To convert the electrophoretic mobility into the zeta
potential, the Helmholtz–Smoluchowski equation was applied. Measurement in conductivity-adjusted
water yields the Stern potential, which is proportional to the surface charge (Nernst potential)
measurement in the original dispersion medium the ZP value suitable for predicting long-term stability.
2.5. In-Vitro Antioxidant Activity
For the comparison of the antioxidant activity of the prepared rutin nanocrystal gel with rutin
bulk powder gel (both described in Section 2.3), a DPPH (2,2-diphenyl-1-picrylhydrazyl) assay was
performed using a methanolic DPPH solution having its absorbance adjusted at 1 by a wavelength
of 517 nm (UV maximum of methanolic DPPH solution). The UV absorbance was controlled with
an UV-1700 PharmaSpec (Shimadzu Deutschland GmbH, Duisburg, Germany) using optically clear
cuvettes with a total volume of 4.5 mL (VWR International GmbH, Darmstadt, Germany). Samples
were prepared by suspending 0.5 g of gel in 2.5 g methanol using an Edmund BühlerSwip KS-10
(Hechingen, Germany) for one hour at 20 ˝C and 150 rpm. With an Eppendorf Centrifuge 5451
C (Hamburg, Germany), undissolved particles were separated from supernatant, since particles
can scatter UV light and thus take influence on UV measurement. Seventy-five microliters of the
clear supernatant was added into a cuvette with 1.5 mL methanolic DPPH solution and the UV
absorbance was measured over a time period of 60 min again at 517 nm with the PharmaSpec UV-1700.
For zero adjustment, 1.5 mL methanolic DPPH solution was diluted with 75 µL Miglyol 812. The
rutin nanocrystal gel was also compared with already marketed dermal products, having rutin or its
water-soluble derivatives, i.e., disodium rutinyl disulfate and troxerutin, as active compound. The
price of the products varied strongly from €8.00 to €220.00 (retail shop price). All samples were
measured six-fold.
2.6. Ex-Vivo Penetration Study on Porcine Ear Skin
To determine the penetration profiles of the rutin nanocrystal gel and raw drug powder gel
(Section 2.3), an ex vivo penetration study was performed using the tape stripping method on porcine
ears directly on the day of slaughter. The fresh ears were prepared by removing the hair neatly with a
scissor and cleaning the surface with purified water at 20 ˝C. The ears were then patted dry with a soft
paper tissue. As investigation area of 2 cm ˆ 4 cm was defined and only intact skin was used showing
no injuries or other visible skin changes.
Thus, on one porcine ear, only two to maximum three investigation areas can fit, but for a sufficient
explanatory power a three-fold determination and thus at least six areas were necessary. Since the
porcine ears are strongly varying among each other from biological side, it was pointless to pool
together penetration profiles of one formulation observed on different porcine ears. Therefore the
idea was not to compare the penetration profiles directly with each other from different ears but the
relation between the penetration profiles of the rutin nanocrystal and raw drug powder gel (Section 2.3)
investigated on one and the same ear with the relation investigated on another ear. Thus, in this
study, two investigation areas were set on one porcine ear investigating the penetration of the rutin
nanocrystal gel and raw drug powder gel.
Onto one investigation area, 20 mg of gel was applied homogenously. After a penetration time
of 40 min, 30 adhesive tapes (tesa Film No. 5529, Beiersdorf, Germany) were used to remove the
stratum corneum layer by layer. The amount of adhering corneocytes represents the thickness of
removed horny layer with the tape and was determined for a 1 cm ˆ 1 cm area by UV analysis using a
Lambda 20 (PerkinElmer, Waltham, MA, USA) at a wavelength of 800 nm. Afterwards, removed rutin
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was quantitatively extracted from the tapes having a size of 1.9 cm ˆ 3.5 cm in 2.0 mL of acetonitrile
and dimethyl sulfoxide (ration of 1:1) by shaking with an Edmund BühlerSwip KS-10 (Hechingen,
Germany) for 1 h at 150 rpm. The concentration of rutin was analyzed using high-performance
liquid chromatography (Section 2.7). The relative amount of rutin in each tape was calculated by
following equation:
rel. amount o f rutin r%s “ total amount o f rutin detected in a certain tape
sum o f rutin amounts detected in all 30 tapes
ˆ 100% (1)
2.7. High-Performance Liquid Chromatography (HPLC)
Rutin concentrations were determined using a Kroma System 2000 version 1.7 (Kontron
Instruments GmbH, Augsburg, Germany) combined with a solvent delivery pump equipped (Kontron
Instruments SpA, Milano, Italy) consisted of a 20 µL loop, an auto sampler model 560 and an UV
detector model 430 measuring at a wavelength of 255 nm. A Eurospere® C18 RS (250 mm ˆ 4.6 mm)
was used as analytical column and acetic buffer (pH 4.8) with acetonitrile in a ratio of 8:2 (v/v) were
used as solvent system. Each sample was measured in duplicate.
3. Results and Discussion
3.1. Characterization of Rutin Nanocrystal Suspension and the Nanocrystal Gel
Directly after production, the rutin nanocrystal suspension showed a mean PCS particle size of
240 nm with a polydispersity index of 0.215, consistent with the LD diameter 50% of 285 nm. A slight
increase in particle size was observed after six months of storage at 25 ˝C ˘ 2 ˝C, where the mean
particle size was 318 nm with unchanged polydispersity index and the LD diameter 50% of 311 nm.
For comparison, rutin raw drug powder suspension had a LD diameter 50% of 32.2 µm, which was
unchanged after six months of storage at 25 ˝C ˘ 2 ˝C. The PCS z-average and polydispersity index of
the suspension could not been determined, since the size exceeded the measurement range of PCS.
Based on these data, both suspensions on their own possessed a good physical stability, fulfilling the
precondition for incorporating into a gel base.
Particle growth can be induced when incorporating the suspension into the gel base. Thus, the
particle size of rutin was also investigated in the gel using PCS, LD and LM. A negligible growth of
particle size from 240 nm to 282 nm was observed for rutin nanocrystals, directly after incorporating
it into the gel base. The storage of this gel for three months at 25 ˝C ˘ 2 ˝C did not lead to further
growth; thus, the nanocrystals were physically stable. Results obtained for the rutin raw drug powder
also proved physical stability. After incorporation, the LD diameter 50% showed no significant change
(32.2 µm before and 33.0 µm after incorporation), and remained unchanged during storage. Thus,
there was no destabilizing influence of the gel base onto the particles.
3.2. Safety of Rutin and Rutin Nanocrystals in Dermal Formulations
From the Material Safety Data Sheets (MSDS), rutin as a molecule itself is declared as a save
compound. Admix it into dermal formulations does not affect its safety, proven by the high number of
consumer care and cosmetic products on the market (e.g., Yves Rocher–Sensitive Vegetal, La mer–MED
Couperose Konzentrat Feuchtigkeitspflege, Bio Specific Active–Sensitive Augenpflege, aMENity–After
Shave & Face Moisturizer). Commonly, in the marketed dermal formulations, the active rutin is
either dissolved in very low concentrations or dispersed as raw drug powder. In contrast, the present
formulation (Section 2.3) has rutin incorporated as nanocrystals with particle sizes still being outside
the nanoparticle definition of the legal regulations of the European Cosmetic Decree. In addition to
the particle size above 100 nm, the rutin nanocrystals are biodegradable and thus belong to the green
class (class I) of the nanotoxicological classification system (NCS) [12] underlining the safety of rutin
nanocrystal in the present formulation.
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3.3. In-Vitro Antioxidant Activity
To prove that a particle size reduction of rutin into the nanometer range will increase its
antioxidant activity, a DPPH assay was performed with both rutin nanocrystal gel and raw drug
powder gel (Section 2.3). In addition, the results were compared with the antioxidant activities of facial
cosmetic products available on the market containing rutin, one of its water-soluble derivatives or a
combination of both as active ingredient.
The DPPH is an exceptionally stable free radical since the spare electron is strongly delocalized
over the whole molecule. Thus, the dimerization potential is significantly reduced and this property
enables the DPPH radical to be used for antioxidant activity studies. Two DPPH radicals were
neutralized by one molecule of rutin, which get itself oxidized at the catechol 31,41-dihydroxyl group
(Figure 1).
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Even if the DPPH radical shows artificially high chemical stability, reduction to DPPH-H molecules
can occur during the long measurement period of 60 min by the contact with ambient air. To avoid
incorrect determinations of the antioxidant activity, the reduction of the methanolic DPPH solution on
ambient air was also measured and considered in the equation as A(control). The A(control) sample was
prepared and treated in the same manner as the other samples. Only instead of adding 75 µL extract of
product, neutral oil Miglyol 812 was used. For the conversion of investigated reduction of absorption
to the inhibition of DPPH activity in %, the following equation was used:
inhibition o f DPPH ac ivity r%s “ A pcontrolq ´ A psampleq
A pcontrolq ˆ 100% (2)
Comparing the antioxidant activity of rutin nanocrystal gel (NC gel) with raw drug powder
gel (RDP gel), the superiority in neutralize radicals ca be clearly i entified for the nanocrystal gel
(Figure 2). Already after a reaction time of 5 min, more than 60% of the free radicals were neutralized
to innocuous molecules by the nanocrystal gel. Within the same reaction time, only half (30%) of the
DPPH was educe to DPPH-H by the raw drug powder gel. The maximum inhibition of DPPH
activity for the nanocrystal gel was reached after 30 min and amounted 90%. For the raw drug powder
gel, the maximum was reached after 60 min and amounted to only 40%. Thus, the nanocrystal gel
showed more than twice as strong antioxidant activity as the raw drug powder gel. This result can be
explained by the significantly increased s turation solubility (Cs) of utin as nanocrystal during, and
also for a long time after the dissolution compared to the µm-sized raw drug powder.
In addition, both gels were compared with marketed facial cosmetic products, having rutin, one
of its water-s l ble derivative or a combination of both as active ingredient. Although the investigated
products cannot be named directly, their official retail prices and active co pounds can be mentioned,
categorized and published. Low price products with an official selling price lower than €20.00 were
the products B, C, F and H. Middle price products were D, E, G and I, having an official selling price
between €20.00 nd €100.00. The products more expensive than €100.00 i cluded A and K. Four
different types of rutin were found in the products: rutin nanocrystals (A), rutin raw drug powder
(E and G), disodium rutinyl disulfate (C, D, H, I and K) and troxerutin (J). Combined products were
also on the marked: B with troxerutin and rutin raw drug powder, E with disodium rutinyl disulfate
and rutin raw drug powder and F with troxerutin and disodium rutinyl disulfate.
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Since the antioxidant activity depends on structural features, such as hydroxyl bound dissociation
energy, resonance delocalization of phenol radicals and steric hindrance derived from groups
substituting the hydrogen in the aromatic ring [14], it is to be expected that the change of the chemical
structure to obtain increased water solubility will reduce the antioxidant activity. This assumption
was confirmed by the results of the DPPH assay (Figure 2). While the rutin nanocrystal gel was able
to inhibit 90% of the DPPH activity, the maximum DPPH inhibition among all tested products with
water-soluble derivatives of rutin (C, D, F, H, I, J and K) was less than 50%.
Generally, the antioxidant activities of the tested products can be categorized into three classes:
I, II and III, where class I products were able to neutralize more than 80% of the DPPH radicals to
DPPH-H molecules (A), class II products less than 80% but more than 20% (B, C, D, E and F) and class
III, showing almost no reduction in DPPH activity and thus had no antioxidant properties (G, H, I, J
and K).
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Figure 2. Comparison of the antioxidant activities with DPPH assay of rutin nanocrystal gel, raw drug
powder gel and facial cosmeti products, having rutin, its water-soluble derivative or a combination of
both as active ingredient.
No relationship between the price of a product and its antioxidant activity can be drawn. For
example, the product B with the second highest DPPH inhibit on of just below 70% can be purchased
for €10.99 and has the same price as product H with a DPPH inhibition below 10% (Figure 2). Both
A and K are also in the same price category with official selling prices above €100.00. While product
A exhibits the highest DPPH inhibition of 85% among the tested marketed products, K shows no
antioxidant activity reflected by the DPPH inhibition of 0% (Figu e 2).
Even more interesting was the finding that there are also no clear relationships between the type
of incorporated rutin and the antioxidant activity of the product exhibited. For example, rutin raw
drug powder was the active agent in both product E and G. Product E was able to neutralize more than
30% of the DPPH radicals, whil G cou d not even nhibit 10% of the DPPH radical activity. The same
pattern was observed for the products C and D and H, I, and K. All five products have disodium rutinyl
disulfate incorporated, but only product C and D showed inhibition effects on DPPH of 50% and 40%,
respectively. In contrast, the products H, I and K had nearly no neutralizing effect on the free radical
DPPH. The highest antioxidant activity among the products was obtained for product A. It showed
almost the same curve progression as the nanocrystal gel. By reading through the advertisement of the
company, it was found that this product has rutin incorporated as nanocrystal as well.
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To summarize, this in vitro antioxidant activity study revealed the superiority of rutin nanocrystal
gel compared to rutin raw drug powder and its water-soluble derivatives with respect to the
antioxidant activity.
3.4. Ex-Vivo Penetration Study on Porcine Ears
One of the well-known advantages of nanocrystals is the increased saturation solubility
and increased dissolution velocity of actives. The solubility reported for rutin nanocrystals is
133 µg/mL [15]. Since the penetration into the skin takes place by passive diffusion, the increased
saturation solubility will automatically lead to a higher concentration gradient between gel and skin
and thus to an improved skin penetration. To assess this theory, an ex vivo penetration study on porcine
ear skin was performed and the penetration depth and relative amount of penetrated rutin within the
stratum corneum was investigated for rutin nanocrystal gel (LD diameter 50% of 353 nm) and rutin
raw drug powder gel (LD diameter 50% of 33.0 µm).
An improved penetration of rutin into the porcine ear skin is given when rutin with lower
concentrations remains in the upper part of the stratum corneum (first 20%) and in contrast penetrates
in the deeper layers (70% to 100%) of the stratum corneum with higher concentrations. Comparing the
penetration profile of both gels determined on one and the same porcine ear (Figure 3), this applies to
the rutin nanocrystal gel. In the upper part of the stratum corneum, represented by the depths of 10%
and 17%, 2.5- and 2.0-fold less relative amount of rutin could be found, respectively. The middle part
of the stratum corneum reveals no major differences according to the rutin concentration. In the deeper
part of the stratum corneum, represented by the depths of 70% and 80%, 3.0- and 5.0-fold increased
concentration was obtained for the rutin nanocrystal gel.
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Similar observations were made for the other two investigated porcine ears. In the upper part of
the stratum corneum, represented by the depths of 15%, 1.8- and 2.4-fold less relative amount of rutin
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could be found, where in the deeper part of the stratum corneum, represented by the depths of 80%,
4.7- and 5.4-fold increased concentrations were obtained for the rutin nanocrystal gel.
No difference in penetration depth was investigated between both formulations since the used
30 tapes only removed approximately 84% [16] of the whole stratum corneum. However, the course
of the penetration curve suggests that the penetration depth would have been deeper for the rutin
nanocrystal gel.
In summary, the results of the ex vivo penetration study reveal clearly the improved penetration
profile of rutin applied as nanocrystal gel. The increase in skin penetration pared with the superior
antioxidant activity suggests a promising dermal bioactivity.
4. Conclusions
The transfer of the µm-sized rutin raw drug powder into nanocrystals could distinctly increase
the in vitro antioxidant activity of rutin. In addition, rutin nanocrystals showed increased skin
penetration. Both effects are attributed to the increase in the saturation solubility by nanocrystal
formation (e.g., increased concentration gradient between dermal formulation and skin, thus increased
passive flux into the skin). Both the developed rutin nanocrystal gel and the commercial nanocrystal
based product A showed the highest antioxidant activity compared to products with rutin raw drug
powder and/or water-soluble rutin derivatives.
The enhanced radical scavenging properties in combination with higher penetration increase the
bioactivity in the skin. Thus, nanocrystal technology is promising for increasing the bioactivity of
the poorly soluble rutin, as the technology proved to increase the bioavailability of various poorly
soluble drugs before. Therefore, the mechanistic principle should be transferable to other poorly
soluble antioxidants.
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